We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
APRE icon
501
Aprea Therapeutics
APRE
$7.68M
$7.68M $0.6200 2.36%
BOLT icon
502
Bolt Biotherapeutics
BOLT
$7.67M
$7.67M $3.99 2.57%
MTVA
503
MetaVia Inc
MTVA
$7.33M
$7.33M $1.42 1.39%
ADIL
504
Adial Pharmaceuticals
ADIL
$7.31M
$7.31M $3.34 1.52%
XTLB
505
XTL Biopharmaceuticals
XTLB
$6.93M
$6.93M $2.82 1.05%
LIMN
506
Liminatus Pharma
LIMN
$6.92M
$6.92M $0.1030 0.88%
TRAW icon
507
Traws Pharma
TRAW
$6.85M
$6.85M $0.4500 2.02%
IMNN icon
508
Imunon
IMNN
$6.68M
$6.68M $1.59 0.63%
ADXN
509
Addex Therapeutics
ADXN
$6.58M
$6.58M $5.20 7.14%
PULM icon
510
Pulmatrix
PULM
$6.35M
$6.35M $1.74 2.35%
ENVB icon
511
Enveric Biosciences
ENVB
$6.32M
$6.32M $1.57 9.79%
ALZN icon
512
Alzamend Neuro
ALZN
$6.28M
$6.28M $1.31 2.96%
CVKD icon
513
Cadrenal Therapeutics
CVKD
$6.23M
$6.23M $2.01 3.83%
ACXP icon
514
Acurx Pharmaceuticals
ACXP
$6.19M
$6.19M $1.44 1.41%
PMCB icon
515
PharmaCyte Biotech
PMCB
$6.18M
$6.18M $0.5760 4%
PCSA icon
516
Processa Pharmaceuticals
PCSA
$5.95M
$5.95M $2.15 5.39%
CURX
517
Curanex Pharmaceuticals
CURX
$5.82M
$5.82M $0.2052 7.43%
XBIO icon
518
Xenetic Biosciences
XBIO
$5.82M
$5.82M $2.54 0.39%
EVGN icon
519
Evogene
EVGN
$5.7M
$5.7M $0.4710 3.76%
SNGX icon
520
Soligenix
SNGX
$5.54M
$5.54M $0.3739 0.29%
NCNA
521
NuCana
NCNA
$5.49M
$5.49M $1.32 4.76%
BCAB icon
522
BioAtla
BCAB
$5.46M
$5.46M $3.29 2.66%
BRTX icon
523
BioRestorative Therapies
BRTX
$5.22M
$5.22M $0.2047 9.22%
CLGN icon
524
CollPlant Biotechnologies
CLGN
$5.16M
$5.16M $0.2728 9.04%
GLMD icon
525
Galmed Pharmaceuticals
GLMD
$5.13M
$5.13M $0.6210 3.67%
19 20
21
22 23

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.2T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $121B, Regeneron Pharmaceuticals (REGN) at $78.5B and argenx (ARGX) at $53.4B.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.